BAYER AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.02 EUR | -0.39% |
|
+2.26% | -16.68% |
| May. 02 | European Equities Close Mostly Lower in Thursday Trading; Eurozone Manufacturing Remains in Contraction | MT |
| May. 02 | Manufacturing Downturn Keeps German Stocks Lower | MT |
| Sales 2024 * | 47.09B 50.67B | Sales 2025 * | 47.95B 51.6B | Capitalization | 27.53B 29.62B |
|---|---|---|---|---|---|
| Net income 2024 * | 2.08B 2.24B | Net income 2025 * | 3.17B 3.41B | EV / Sales 2024 * | 1.29 x |
| Net Debt 2024 * | 33.1B 35.62B | Net Debt 2025 * | 29.67B 31.93B | EV / Sales 2025 * | 1.19 x |
| P/E ratio 2024 * |
12.8
x | P/E ratio 2025 * |
8.62
x | Employees | 96,931 |
| Yield 2024 * |
0.39% | Yield 2025 * |
0.83% | Free-Float | 99.97% |
More Fundamentals
* Assessed data
More news
Latest transcript on Bayer AG
More press releases
| 1 day | -0.39% | ||
| 1 week | +2.26% | ||
| Current month | +2.45% | ||
| 1 month | -2.59% | ||
| 3 months | -2.34% | ||
| 6 months | -33.38% | ||
| Current year | -16.68% |
1 week
27.27
28.82
1 month
25.6128.82
Current year
24.9636.09
1 year
24.9658.70
3 years
24.9667.99
5 years
24.9678.34
10 years
24.96146.45
| Managers | Title | Age | Since |
|---|---|---|---|
William Anderson
CEO | Chief Executive Officer | 57 | 23-03-31 |
| Director of Finance/CFO | 55 | 18-04-25 | |
Bijoy Sagar
CTO | Chief Tech/Sci/R&D Officer | 55 | 20-03-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Colleen Goggins
BRD | Director/Board Member | 68 | 17-03-31 |
Alberto Weisser
BRD | Director/Board Member | 67 | 21-03-31 |
Paul Achleitner
BRD | Director/Board Member | 67 | 02-03-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 9.77% | 70 M€ | -.--% | - | |
| 5.71% | 2 M€ | +13.56% | - | |
| 4.28% | 962 M€ | -.--% | - | |
| 4.10% | 0 M€ | 0.00% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-03 | 28.02 | -0.39% | 2,582,716 |
| 24-05-02 | 28.13 | +2.85% | 5,554,757 |
| 24-04-30 | 27.35 | -0.87% | 3,426,001 |
| 24-04-29 | 27.59 | +0.69% | 2,430,613 |
| 24-04-26 | 27.4 | +1.88% | 4,690,278 |
Delayed Quote Xetra, May 03, 2024 at 11:35 am EDT
More quotes
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:
- agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC products and nutritional supplements (12.7%);
- other (0.5%).
Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Sector
Pharmaceuticals
Calendar
2024-05-14
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
28.02
EUR
Average target price
36.9
EUR
Spread / Average Target
+31.71%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -16.68% | 29.65B | |
| +21.85% | 546B | |
| -4.77% | 359B | |
| +16.97% | 323B | |
| +5.69% | 290B | |
| +13.68% | 234B | |
| +3.65% | 198B | |
| -11.12% | 194B | |
| +8.08% | 167B | |
| -3.40% | 157B |
- Stock Market
- Equities
- BAYN Stock
